InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: wcopeland post# 804

Friday, 04/07/2017 12:49:59 PM

Friday, April 07, 2017 12:49:59 PM

Post# of 2099
Agree on all points, wcopeland, including how Dror comes off as being confident/excited and enjoying his discussion with other scientists. Excellent summary - thank you.

Btw, regarding potential partners "Currently BMS, Merck & Co. and Roche have PD1/PD-L1 modulators on the market. Astra Zeneca’ s PD-L1 blocker durvalumab is expected to reach the market this autumn". As I mentioned in an earlier post, Ramy Ibrahim has strong connections with AZ and with AZ being late to the party, I'm beginning to lean towards AZ as the potential partner.

http://european-biotechnology.com/up-to-date/news-and-stories/news/fda-approves-mercks-avelumab-in-mcc.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News